PT Medikaloka Hermina Tbk

IDX:HEAL Stock Report

Market Cap: Rp19.1t

Medikaloka Hermina Management

Management criteria checks 2/4

Medikaloka Hermina's CEO is H. Hasmoro, appointed in Jan 1991, has a tenure of 34.17 years. directly owns 4.89% of the company’s shares, worth IDR935.95B. The average tenure of the management team and the board of directors is 4.5 years and 7.2 years respectively.

Key information

H. Hasmoro

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure34.2yrs
CEO ownership4.9%
Management average tenure4.5yrs
Board average tenure7.2yrs

Recent management updates

Recent updates


CEO

H. Hasmoro (80 yo)

34.2yrs

Tenure

Dr. H. Hasmoro, Sp An, KIC, MHA, MM, has been President Director of PT Medikaloka Hermina Tbk since 1991. Previously, Dr. Hasmoro served as Member of Presidential Specialist Team from 1987 to 2000.He join...


Leadership Team

NamePositionTenureCompensationOwnership
H. Hasmoro
President Director34.2yrsno data4.89%
IDR 936.0b
Yulisar Khiat
MD of Finance & Strategic Development and Director1.2yrsno data13.19%
IDR 2.5t
Tan Gunadi
MD of Operational & General Affairs and Director1.2yrsno data0.030%
IDR 5.8b
Binsar Simorangkir
MD of Medical and Compliance & Directorno datano data5.51%
IDR 1.1t
Arie Wahyudi
Head of Licensing & Legalno datano datano data
Muyi Hapsari
Head of Marketingno datano datano data
Susi Setiawaty
MD of Human Capital4.5yrsno data0.0047%
IDR 899.3m
Meijani Wibowo
Commissionerno datano data2.21%
IDR 423.7b
Hastiyudo Wibowo
Business Developmentno datano datano data
Chatarina Sri Marsiyo
Head of Internal Audit4.5yrsno datano data
Yuyun Gunaedi
Information Technologyno datano datano data

4.5yrs

Average Tenure

64.5yo

Average Age

Experienced Management: HEAL's management team is considered experienced (4.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
H. Hasmoro
President Director34.2yrsno data4.89%
IDR 936.0b
Yulisar Khiat
MD of Finance & Strategic Development and Director28.2yrsno data13.19%
IDR 2.5t
Tan Gunadi
MD of Operational & General Affairs and Director1.2yrsno data0.030%
IDR 5.8b
Binsar Simorangkir
MD of Medical and Compliance & Director27.2yrsno data5.51%
IDR 1.1t
Susi Setiawaty
MD of Human Capital1.2yrsno data0.0047%
IDR 899.3m
Meijani Wibowo
Commissioner3.2yrsno data2.21%
IDR 423.7b
Amit Varma
Independent Commissioner5.2yrsno datano data
Alexander Rusli
Independent Commissioner7.2yrsno datano data
Darwin Noerhadi
Commissioner8.2yrsno datano data
Husen Sutakaria
Vice President Commissioner7.2yrsno data2.85%
IDR 544.5b
Paulus Gunawan
President Commissioner8.2yrsno datano data
. Heridadi
Independent Commissioner7.2yrsno datano data

7.2yrs

Average Tenure

65yo

Average Age

Experienced Board: HEAL's board of directors are considered experienced (7.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/14 17:53
End of Day Share Price 2025/03/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Medikaloka Hermina Tbk is covered by 20 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patricia GabrielaCGS International
Jason ChandraCGS International
Lakshmi RowterCitigroup Inc